Growth Metrics

Cellectis (CLLS) EBIAT (2016 - 2023)

Historic EBIAT for Cellectis (CLLS) over the last 10 years, with Q3 2023 value amounting to -$58.2 million.

  • Cellectis' EBIAT fell 8614.11% to -$58.2 million in Q3 2023 from the same period last year, while for Sep 2023 it was -$135.9 million, marking a year-over-year decrease of 10879.46%. This contributed to the annual value of -$106.1 million for FY2022, which is 20716.84% down from last year.
  • As of Q3 2023, Cellectis' EBIAT stood at -$58.2 million, which was down 8614.11% from -$16.6 million recorded in Q2 2023.
  • In the past 5 years, Cellectis' EBIAT registered a high of $46.7 million during Q4 2020, and its lowest value of -$89.2 million during Q3 2021.
  • Its 5-year average for EBIAT is -$27.3 million, with a median of -$31.3 million in 2022.
  • Per our database at Business Quant, Cellectis' EBIAT soared by 21353.81% in 2020 and then crashed by 41574.46% in 2023.
  • Over the past 5 years, Cellectis' EBIAT (Quarter) stood at -$41.2 million in 2019, then surged by 213.54% to $46.7 million in 2020, then tumbled by 117.28% to -$8.1 million in 2021, then crashed by 253.76% to -$28.6 million in 2022, then crashed by 103.78% to -$58.2 million in 2023.
  • Its last three reported values are -$58.2 million in Q3 2023, -$16.6 million for Q2 2023, and -$32.5 million during Q1 2023.